Healthcare -
Biotechnology - NASDAQ - US
$ 17.78
-3.94 %
$ 545 M
Market Cap
-3.47
P/E
CASH FLOW STATEMENT
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
AnaptysBio, Inc.
| Net Income | -145 M |
| Depreciation & Amortization | 2.4 M |
| Capital Expenditures | -358 K |
| Stock-Based Compensation | 34 M |
| Change in Working Capital | 0 |
| Others | -26.6 M |
| Free Cash Flow | -136 M |
Cash Flow
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||||||||
| Net Income | (145.2) | (163.6) | (128.7) | (57.8) | (19.9) | (97.3) | (61.7) | (30.1) | (4.3) | (5.4) | 3.5 | (5.5) |
| Depreciation & Amortization | 2.4 | 2.4 | 2.3 | 2.1 | 0.6 | 0.5 | 0.3 | 0.2 | 0.2 | 0.3 | 0.3 | 0.6 |
| Deferred Income Tax | 0 | 0 | 0 | 0.5 | 0 | (2.6) | (1.2) | 1.4 | 0.8 | 1.3 | 62 K | (0.6) |
| Stock Based Compensation | 34.0 | 33.2 | 27.4 | 15.3 | 11.5 | 12.4 | 10.0 | 4.4 | 1.2 | 0.6 | 0.2 | 0.2 |
| Other Operating Activities | (26.6) | 7.6 | 18.6 | 1.4 | 0.5 | 0.7 | 0.6 | 0.6 | 0.1 | 0.1 | 1.3 | 0.9 |
| Change in Working Capital | 0 | (0.3) | 6.8 | (7.5) | (6.8) | 16.9 | 3.5 | 4.1 | (7.0) | (6.5) | 9.3 | (1.2) |
| Cash From Operations | (135.3) | (120.8) | (73.6) | (45.9) | (14.2) | (69.5) | (48.5) | (19.4) | (9.0) | (9.7) | 14.6 | (5.8) |
| INVESTING CASH FLOW | ||||||||||||
| Capital Expenditures | (0.4) | (0.8) | (0.4) | (1.4) | (0.6) | (0.8) | (1.1) | (0.3) | 50 K | (0.2) | (0.1) | 37 K |
| Other Items | 95.8 | 145.6 | (394.5) | 40.2 | 95.0 | 132.2 | (141.4) | (242.8) | 0 | 0 | 5 K | 0 |
| Cash From Investing Activities | 95.4 | 144.8 | (394.8) | 38.8 | 94.5 | 131.4 | (142.5) | (243.1) | 50 K | (0.2) | (0.1) | 37 K |
| FINANCING CASH FLOW | ||||||||||||
| Common Stock Repurchased | (0.5) | (50.0) | 0 | 0 | 0 | 0 | 0 | 0 | 1 K | 0 | 0 | 0 |
| Total Debt Repaid | 0 | (11.7) | 0 | 0 | (1.4) | (7.5) | (6.9) | 0 | 10.0 | 0 | 5.0 | 2.0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 26.7 | 43 K | 32.2 | 249.7 | 0 | 0 | 2.8 | 84 K | (1.4) | 39.2 | 85 K | 0 |
| Cash From Financing Activities | 127.1 | (59.3) | 44.0 | 252.3 | (0.9) | (4.5) | 223.4 | 292.5 | 8.6 | 39.4 | 4.9 | 2.0 |
| CHANGE IN CASH | ||||||||||||
| Net Change In Cash | 87.1 | (35.3) | (424.4) | 245.2 | 79.4 | 57.4 | 32.4 | 30.0 | (0.5) | 29.5 | 19.4 | (3.9) |
| FREE CASH FLOW | ||||||||||||
| Free Cash Flow | (135.7) | (121.6) | (74.0) | (47.3) | (14.7) | (70.3) | (49.6) | (19.7) | (9.1) | (9.9) | 14.5 | (5.8) |